Expert opinion on therapeutic patents 影响因子
WebExpert opinion: Around a dozen aurora kinase inhibitors are currently undergoing various Phase I - II evaluations for different human cancers. Instead of being applied as a monotherapy, combinations of aurora kinase inhibitors and existing chemotherapeutic compounds seem to give better therapeutic outcomes and are, therefore, a promising … WebEXPERT OPINION ON THERAPEUTIC PATENTS. 出版年份：1994 年文章数：11 投稿命中率：暂无数据. 出版周期：Monthly 自引率：2.7% 审稿周期：暂无数据. 前往期刊查询.
Expert opinion on therapeutic patents 影响因子
Did you know?
WebCT Supuran is Editor-in-Chief of the Expert Opinion on Therapeutic Patents. He was not involved in the assessment, peer review, or decision-making process of this paper. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject ... WebMar 22, 2024 · Expert Opinion on Therapeutic Patents; ABSTRACT Introduction Galectins are ubiquitous in nature. They have established themselves as a protein family of high therapeutic potential and play a role in a wide variety of diseases like cancer, fibrosis, and Alzheimer’s. Within the galectin family, galectin- 1 and galectin- 3 have been widely ...
WebPharmacology & Therapeutics is a medical review journal published by Elsevier. It incorporates Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors and Pharmacology & Therapeutics. Part B: General and Systematic Pharmacology, both originally published by Oxford University Press. ISSN. WebMar 28, 2024 · Publishing reviews and patent evaluations covering recent patent claims/applications on compounds with therapeutic potential, including biotherapeutics …
Web《phytotherapy research》发布于爱科学网，并永久归类相关sci期刊导航类别中，本站只是硬性分析 "《phytother res》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技 … Web介绍. Expert Opinion on Therapeutic Patents (ISSN 1354-3776 [print], 1744-7674 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on recent pharmaceutical patent claims, providing expert opinion the scope for future development, in the context of the scientific literature.
http://www.med126.com/lunwen/2015/20150209210010_1067162.shtml
WebEXPERT OPINION ON THERAPEUTIC PATENTS. 最近收录：更新时间（2024年6月）. 期刊简称（NLM）： EXPERT OPIN THER PAT. 期刊备注：. ISSN刊号： 1354-3776. 研 … university of minnesota alumniWebPubMed Central (PMC)链接：PubMed Central 平均审稿速度：网友分享经验：较慢,6-12周 平均录用比例：网友分享经验：一般 在线出版周期： rebecca ann major fritschleWebScope. Expert Opinion on Therapeutic Patents (ISSN 1354-3776 [print], 1744-7674 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on recent pharmaceutical patent claims, providing expert opinion the scope for future development, in the context of the scientific literature. rebecca ann murphy obituaryWebDobrzyn, A., & Dobrzyn, P. (2008). Inhibition of stearoyl-CoA desaturase by cyclic amine derivatives. Expert Opinion on Therapeutic Patents, 18(4), 457–460. doi:10. ... rebecca ann shaferWebJan 2, 2024 · Expert Opinion on Therapeutic Patents; ABSTRACT Introduction: Boswellic acids (BAs), a group of pentacyclic triterpenoids, have demonstrated very interesting biological properties that resulted in a number of protocols being developed for their synthesis. During the last twenty-five years (1990–2015), numerous BAs have been … rebecca ann stewart lexington kyWebOnline access. Online archive. Expert Opinion on Therapeutic Patents is a monthly peer-reviewed medical journal covering pharmaceutical patent information across all therapy areas. Each review includes an "expert opinion" section, in which authors provide their personal view on the current status and future direction of the research discussed. rebecca ann lathamWebManzo, F., Tambaro, F. P., Mai, A., & Altucci, L. (2009). Histone acetyltransferase inhibitors and preclinical studies. Expert Opinion on Therapeutic Patents, 19(6 ... rebecca ann stringer